Biogen dumps dubious Alzheimer’s drug after profit-killing FDA scandal
Enlarge / The exterior of the headquarters of biotechnology company Biogen in Cambridge, Massachusetts. (credit: Getty | Boston Globe) Biotechnology company Biogen is abandoning Aduhelm, its questionable Alzheimer’s drug that…